Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-50,000
Closed -$4.63M 10287
2024
Q4
$4.63M Buy
+50,000
New +$4.81M ﹤0.01% 3925
2024
Q3
Sell
-48,600
Closed -$3.64M 9569
2024
Q2
$3.64M Sell
48,600
-19,400
-29% -$1.55M ﹤0.01% 3162
2024
Q1
$5.87M Buy
+68,000
New +$5.2M ﹤0.01% 2794

Other funds holding CRH

UBS Group's CRH Position: Q1 2026 in Review

UBS Group reduced its CRH (CRH) stake by 38% in Q1 2026, selling an estimated $282M and leaving 3,944,361 shares worth $415M. The position accounts for 0.06% of the portfolio, ranked #313.

UBS Group first reported a position in CRH in Q4 2014 and has held it in 46 quarters since. The position peaked at $874M in Q1 2025. 1,006 funds tracked by Wall St. Rank hold CRH as of Q1 2026.

  • UBS Group held 3,944,361 shares of CRH worth $415M as of Q1 2026.
  • UBS Group sold 2,399,531 CRH shares in Q1 2026, an estimated $282M.
  • CRH made up 0.06% of UBS Group's portfolio in Q1 2026, its #313 holding.
  • UBS Group first reported a position in CRH in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's CRH position peaked at $874M in Q1 2025.
  • 1,006 funds tracked by Wall St. Rank held CRH as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.